These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17219700)

  • 1. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical guidelines for overactive bladder.
    Yamaguchi O; Nishizawa O; Takeda M; Yokoyama O; Homma Y; Kakizaki H; Obara K; Gotoh M; Igawa Y; Seki N; Yoshida M;
    Int J Urol; 2009 Feb; 16(2):126-42. PubMed ID: 19228224
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin: does the black box warning justify change in practice?
    Narayanan UG
    Dev Med Child Neurol; 2011 Feb; 53(2):101-2. PubMed ID: 21244406
    [No Abstract]   [Full Text] [Related]  

  • 5. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
    Leong RK; De Wachter SG; van Kerrebroeck PE
    Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injections into the detrusor.
    Wöllner J; Kessler TM
    BJU Int; 2011 Nov; 108(9):1528-37. PubMed ID: 22023061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Jan; 77(1):41-4. PubMed ID: 10333697
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in paediatric urology: a systematic literature review.
    DasGupta R; Murphy FL
    Pediatr Surg Int; 2009 Jan; 25(1):19-23. PubMed ID: 18953547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 13. [Botulinum toxin in urology].
    Gamé X; Karsenty G
    Prog Urol; 2006 Nov; 16(4 Suppl FMC):24-7. PubMed ID: 17183968
    [No Abstract]   [Full Text] [Related]  

  • 14. Repeated botulinum toxin injections: a new answer for further questions.
    Lazzeri M
    Eur Urol; 2007 Dec; 52(6):1571-3. PubMed ID: 17854985
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary management of overactive bladder.
    Smith AL; Wein AJ
    Postgrad Med; 2012 Jan; 124(1):104-16. PubMed ID: 22314120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's perspective of botulinum toxin treatment for overactive bladder symptoms.
    Digesu GA; Panayi D; Hendricken C; Camarata M; Fernando R; Khullar V
    Int Urogynecol J; 2011 Apr; 22(4):425-31. PubMed ID: 21104404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
    White WM; Pickens RB; Doggweiler R; Klein FA
    J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin in the treatment of spasticity].
    Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
    Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
    Nitti VW; Dmochowski R; Sand PK; Forst HT; Haag-Molkenteller C; Massow U; Wang J; Brodsky M; Bavendam T
    J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.